Safety and Efficacy of PF-06650833, PF-06700841, and PF-06826647 in Adults with Moderate to Severe Hidradenitis Suppurativa
Safety and Efficacy of PF-06650833, PF-06700841, and PF-06826647 in Adults with Moderate to Severe Hidradenitis Suppurativa. A Phase 2a, Multicenter, Randomized, Double-Blind,
Placebo-Controlled, 16-Week Study Evaluating the Safety and Efficacy of PF-06650833, PF-06700841, and PF-06826647 in Adults with Moderate to Severe Hidradenitis Suppurativa.
Category & Conditions: Skin Diseases and Conditions
Medicine: PF-06650833
PF-06700841
PF-06826647
ClinicalTrials.gov Identifier (NCT): NCT04092452
Protocol ID: C2501007
PrintDownloadOpen Plain Language Summary Result: Click here